Platelet CD40 Exacerbates Atherosclerosis by Transcellular Activation of Endothelial Cells and Leukocytes
Author(s) -
Norbert Gerdes,
Tom Seijkens,
Dirk Lievens,
Marijke J. E. Kuijpers,
Holger Winkels,
Delia Projahn,
Helene Hartwig,
Linda Beckers,
Remco T. A. Megens,
Louis Boon,
Randolph J. Noelle,
Oliver Soehnlein,
Johan W. M. Heemskerk,
Christian Weber,
Esther Lutgens
Publication year - 2016
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.115.307074
Subject(s) - platelet , cd40 , platelet activation , inflammation , cell adhesion molecule , hemostasis , p selectin , platelet adhesiveness , endothelium , immunology , chemistry , medicine , biochemistry , in vitro , platelet aggregation , cytotoxic t cell
Beyond their eminent role in hemostasis and thrombosis, platelets are recognized as mediators of inflammation. Platelet cluster of differentiation 40 (CD40) ligand (CD40L and CD154) plays a key role in mediating platelet-induced inflammation in atherosclerosis. CD40, the receptor for CD40L, is present on platelets; however, the role of CD40 on this cell type is until now undefined.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom